Fortress Biotech, Inc.
FBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001429260
No open-market purchases or sales by Fortress Biotech, Inc. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $17.7M in total; no superinvestor holds it.
Other share classesFBIOP
Q1 2026 vs. Q4 2025
How the institutions holding Fortress Biotech, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 52 | 2 | 52 | +2 |
| Shares | 5.79M | 1.10M | 5.36M | +670.3K (+14.3%) |
| Value | $21.2M | $4.03M | $15.0M | −$2.24M (−13.0%) |
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Fortress Biotech, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 966,030 | $2.70M | 0.00% |
| Citadel Advisors LLC | 180,289 | $503.0K | 0.00% |
| Vanguard Fiduciary Trust Co | 142,535 | $397.7K | 0.00% |
| Simplex Trading, LLC | 58,329 | $162.7K | 0.01% |
| Acadian Asset Management LLC | 40,450 | $112.0K | 0.00% |
| Two Sigma Securities, LLC | 24,744 | $69.0K | 0.01% |
| Vanguard Global Advisers, LLC | 12,578 | $35.1K | 0.00% |
| Tower Research Capital LLC (TRC) | 10,495 | $29.3K | 0.00% |
| Rockefeller Capital Management L.P. | 4,812 | $13.4K | 0.00% |
| Federated Hermes, Inc. | 1,261 | $3.52K | 0.00% |
| Royal Bank of Canada | 687 | $2.00K | 0.00% |
| FMR LLC | 220 | $614 | 0.00% |
| Caitong International Asset Management Co., Ltd | 213 | $594 | 0.00% |
Sold out (11)
Institutions that held Fortress Biotech, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Group One Trading, L.P. | 63,692 | $233.1K |
| Wealth Enhancement Advisory Services, LLC | 51,017 | $214.8K |
| Man Group plc | 52,653 | $192.7K |
| Quadrature Capital Ltd | 49,096 | $179.7K |
| PVG Asset Management Corp | 38,788 | $142.0K |
| Two Sigma Advisers, LP | 25,250 | $92.4K |
| Envestnet Asset Management Inc | 23,508 | $86.0K |
| Visionary Wealth Advisors | 11,235 | $41.1K |
| SRS Capital Advisors, Inc. | 4,086 | $15.0K |
| National Bank of Canada | 2,400 | $8.78K |
| Bank of America Corp | 459 | $1.68K |
Not filed for Q1 2026 yet (2)
Institutions that held Fortress Biotech, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 1,100,570 | $4.03M |
| Motiv8 Investments LLC | 33 | $0 |